These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23442728)

  • 1. Identification of effective screening strategies for cardiovascular disease prevention in a developing country: using cardiovascular risk-estimation and risk-reduction tools for policy recommendations.
    Selvarajah S; Haniff J; Kaur G; Guat Hiong T; Bujang A; Chee Cheong K; Bots ML
    BMC Cardiovasc Disord; 2013 Feb; 13():10. PubMed ID: 23442728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trial.
    Diederichsen AC; Rasmussen LM; Søgaard R; Lambrechtsen J; Steffensen FH; Frost L; Egstrup K; Urbonaviciene G; Busk M; Olsen MH; Mickley H; Hallas J; Lindholt JS
    Trials; 2015 Dec; 16():554. PubMed ID: 26637993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy options.
    Kypridemos C; Allen K; Hickey GL; Guzman-Castillo M; Bandosz P; Buchan I; Capewell S; O'Flaherty M
    BMJ; 2016 Jun; 353():i2793. PubMed ID: 27279346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health and Economic Implications of National Treatment Coverage for Cardiovascular Disease in India: Cost-Effectiveness Analysis.
    Basu S; Bendavid E; Sood N
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):541-51. PubMed ID: 26555122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mass and targeted screening strategies for cardiovascular risk: simulation of the effectiveness, cost-effectiveness and coverage using a cross-sectional survey of 3921 people.
    Lawson KD; Fenwick EA; Pell AC; Pell JP
    Heart; 2010 Feb; 96(3):208-12. PubMed ID: 19737737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic differences in the cost-effectiveness of targeted and mass screening for high cardiovascular risk in the UK: cross-sectional study.
    Baker J; Mitchell R; Lawson K; Pell J
    Heart; 2013 Dec; 99(23):1766-71. PubMed ID: 24092057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer screening and health system resilience: keys to protecting and bolstering preventive services during a financial crisis.
    Martin-Moreno JM; Anttila A; von Karsa L; Alfonso-Sanchez JL; Gorgojo L
    Eur J Cancer; 2012 Sep; 48(14):2212-8. PubMed ID: 22424881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term renal and cardiovascular risk after preeclampsia: towards screening and prevention.
    Paauw ND; Luijken K; Franx A; Verhaar MC; Lely AT
    Clin Sci (Lond); 2016 Feb; 130(4):239-46. PubMed ID: 26769659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Health policy interventions: the pathway to public health].
    Andersen K; Gudnason V
    Laeknabladid; 2013 Mar; 99(3):129-34. PubMed ID: 23486685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of preventive screening and lifestyle interventions in women with a history of preeclampsia: A micro-simulation study.
    Lagerweij GR; Brouwers L; De Wit GA; Moons K; Benschop L; Maas A; Franx A; Wermer M; Roeters van Lennep JE; van Rijn BB; Koffijberg H
    Eur J Prev Cardiol; 2020 Sep; 27(13):1389-1399. PubMed ID: 32054298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of policy options for prevention and control of cervical cancer in Thailand.
    Praditsitthikorn N; Teerawattananon Y; Tantivess S; Limwattananon S; Riewpaiboon A; Chichareon S; Ieumwananonthachai N; Tangcharoensathien V
    Pharmacoeconomics; 2011 Sep; 29(9):781-806. PubMed ID: 21838332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis.
    Welton NJ; McAleenan A; Thom HH; Davies P; Hollingworth W; Higgins JP; Okoli G; Sterne JA; Feder G; Eaton D; Hingorani A; Fawsitt C; Lobban T; Bryden P; Richards A; Sofat R
    Health Technol Assess; 2017 May; 21(29):1-236. PubMed ID: 28629510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of lead poisoning screening strategies following the 1997 guidelines of the Centers for Disease Control and Prevention.
    Kemper AR; Bordley WC; Downs SM
    Arch Pediatr Adolesc Med; 1998 Dec; 152(12):1202-8. PubMed ID: 9856430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.
    Boersma C; Gansevoort RT; Pechlivanoglou P; Visser ST; van Toly FF; de Jong-van den Berg LT; de Jong PE; Postma MJ;
    Clin Ther; 2010 Jun; 32(6):1103-21. PubMed ID: 20637965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of a community-based cardiovascular disease prevention intervention in medically underserved rural areas.
    Wang H; Kenkel D; Graham ML; Paul LC; Folta SC; Nelson ME; Strogatz D; Seguin RA
    BMC Health Serv Res; 2019 May; 19(1):315. PubMed ID: 31096977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of cost-effectiveness analyses.
    Hurley S
    Med J Aust; 1990 Aug; 153(S1):S20-3. PubMed ID: 2116583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allocating funds for cardiovascular disease prevention in light of the NCEP ATP III guidelines.
    Caro J; Huybrechts KF; Klittich WS; Jackson JD; McGuire A;
    Am J Manag Care; 2003 Jul; 9(7):477-89. PubMed ID: 12866627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHO/ISH total risk approach for primary prevention of cardiovascular disease shows greater decrease in costs for women but not the elderly in Jamaica.
    Abdulkadri AO; Tulloch-Reid MK; Francis DK; Gordon-Strachan GM; Younger-Coleman NO; Rocke KD; McFarlane SR; Cunningham-Myrie CA; Ferguson TS; Wilks RJ; Anderson SG
    J Clin Epidemiol; 2015 Sep; 68(9):994-1001. PubMed ID: 25819490
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.